Company information:
Aimmune Therapeutics Uk Limited (No: 09559128)
Address: NESTLE HOUSE, HAXBY ROAD, YORK, YO31 8TA, ENGLAND
Status: Operating Company
Incorporated: 24-Apr-2015
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 05-Aug-2025
Industry Class: 21100 - Manufacture of basic pharmaceutical products
Current Director: ERIC HANS CLAUDE BJERKHOLT ( DOB: Jun-1959 From: Nov-2018 )
Current Director: KATARZYNA MALGORZATA CHOINSKA ( DOB: May-1972 From: Mar-2024 )
Current Director: KATARZYNA MALGORZATA CHOINSKA ( DOB: May-1972 From: Mar-2024 )
Current Director: KATARZYNA MALGORZATA CHOINSKA ( DOB: May-1972 From: Mar-2024 )
Current Director: CLAUDIO KUONI ( DOB: Aug-1967 From: Jan-2021 )
Current Director: DOUGLAS THOMAS SHEEHY ( DOB: Dec-1966 From: Mar-2017 )
Resigned Director: SUSAN ELIZABETH BARROWCLIFFE ( DOB: Dec-1958 From: Jan-2016 To: Jan-2019 )
Resigned Director: WARREN DESOUZA ( From: Apr-2015 To: Mar-2017 )
Resigned Director: STEPHEN DILLY ( From: Apr-2015 To: Jun-2018 )
Resigned Director: NICOLAS PIERRE JEAN MARIE FOUCHE ( DOB: Jun-1977 From: Jul-2022 To: Jun-2023 )
Resigned Director: JAMES NELSON PEPIN ( DOB: Aug-1975 From: Nov-2020 To: Nov-2023 )
Resigned Director: MATTHIEU ALBERT WEBER ( DOB: Oct-1971 From: Jul-2022 To: Jan-2024 )
Resigned Secretary: CROWE CLARK WHITEHILL LLP ( From: Apr-2015 To: Mar-2019 )
Persons of Significant Control:
Nestle Sa, 55 Avenue Nestle, 1800 Vevey, 01800, Switzerland: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2019-12-30)
Aimmune Therapeutics Inc., 8000 Marina Boulevard, Suite 300, Brisbane, California, 94005-1884, United States: Ownership of shares – 75% or more (Notified: 2016-04-06, Ceased: 2019-12-30)